|Videos|July 21, 2017

What is the Best Way to Determine an Alternative Agent During a Drug Shortage?

Milena McLaughlin, PharmD, MSc, explains the best way to determine an alternative agent during a drug shortage.

Milena McLaughlin, PharmD, MSc, Assistant Professor, Pharmacy Practice, Midwestern University and Northwestern Memorial Hospital, explains the best way to determine an alternative agent during a drug shortage.

Interview Transcript (slightly modified for readability)

“The best way to determine an alternative agent during a drug shortage is really to look at the medical literature. Some medications in a drug class will be a clear, alternative agent; there may be several in the same drug class, and sometimes the medication alternative is not as clear.

In that case, you really have to go to the medical literature, see what the second-line agent might be, make sure that the adverse effects and the risk versus benefits are there, and that [you’re] really picking the best one. Making sure that the stakeholders, again, are approving this, and that they know why [you’re] going to the second-line agent, and getting all the experts involved in the institution.

Again, making sure that nursing leadership knows what’s going on, so that everyone can be educated on what to expect from that second-line agent, because there’s a reason that it’s the second-line agent, and [you] want to make sure that [you] know what [you’re] getting into with that.”


Related to this article

Ceftriaxone Safety: Separating Signal From Risk
A retrospective multihospital study found that severe adverse events occurred at similarly low rates with ceftriaxone and other IV cephalosporins suggesting there is no evidence to support avoiding ceftriaxone despite recent health department safety alerts.
Treatment of Latent Tuberculosis in a Trice
A retrospective study of 225 patients across Cook County Department of Health clinics found that the novel 1-month 1HP regimen (isoniazid plus rifapentine) for latent TB infection had a completion rate comparable to standard longer regimens and was well tolerated, suggesting it may be a viable shorter alternative.
Peggy Lillis Foundation Will Honor C diff Advocates at Annual Gala
The Peggy Lillis Foundation will host its 17th Annual Changing the Odds Gala this month in New York City, and it will include a casino, fellowship amongst the C diff community, and an award ceremony honoring a physician-scientist, philanthropist, a researcher, and a patient advocate for their contributions to C difficile awareness, treatment, and prevention.